miR-486-3p targets and downregulates the deacetylase Sirtuin 2 (SIRT2), resulting in decreased α-synuclein-induced toxicity in vitro, and suggesting that miR-486-3p may protect against Parkinson’s disease progression [29]. This evidence concerns the gene SIRT2 and Parkinson disease.